Opus Share Price

Opus Share Price

NASDAQ: IRD | Micro Cap | Healthcare
$4.09
+$0.18 (4.60%) Last updated on 20 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Opus Stock Performance

Open
$3.96
Prev. Close
$3.91
Circuit Range
N/A
Day Range
$3.93 - $4.12
Year Range
$1.81 - $7.05
Volume
33,578
Average Traded
$4.02

Opus Share Price Today

As of 20 November 2026, Opus Genetics, Inc.'s share price is $4.09. The stock opened at $3.96, compared to its previous close of $3.91. During today's trading session, Opus Genetics, Inc.'s share price traded between $3.93 and $4.12, with an average price of $4.03. Over the past 52 weeks, the stock has recorded a high of $7.05 and a low of $1.81. In terms of performance, Opus Genetics, Inc.'s share price has declined by 6.19% over the last six months and is up 93.84% on a year-on-year basis.

Opus Share Price Chart

Line chart of the Opus price trend over the selected period. The price rose overall, ranging from 3.91 to 4.12, ending at 3.93.
$3.93$4.12
L
Show Current Price
H

Opus Stock Fundamentals & Key Indicators

Market Cap
$254.49M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.41
Revenue (TTM)
$14.20B
Return On Equity (TTM)
-355.57%
Profit Margin
-349.23%
Debt to Equity
0.90
Quarterly Earnings Growth YoY
-181.48%

Opus Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$3.87$2.16$0.76$1.14
Net Profit-$16.52-$65.54-$8.10-$46.50
Net Profit Margin-426.87%-3034.26%-1065.79%-4078.95%
Income ChangeN/A-296.73%87.64%-474.07%

Opus Annual Profit & Loss

All figures in USD

Particulars20242025
Revenue$10.99$14.20
Net Profit-$57.53-$49.59
Net Profit Margin-523.48%-349.23%
Income ChangeN/A13.80%

Opus Balance Sheet

All figures in USD Million

Particulars20252024
Non Current Assets0.20.25
Current Assets50.0436.61
Total Assets50.2436.86
Non Current Liabilities27.110.0
Current Liabilities7.7811.3
Total Liabilities34.911.3
Shareholders' Equity15.356.72

Opus Cash Flow

Annually

All figures in USD Million

Particulars20252024
Operating-35.25-25.58
Investing0.01.21
Financing50.024.19

About Opus

Opus Genetics Inc is a clinical-stage ophthalmic biopharmaceutical company developing therapies to treat patients with inherited retinal diseases (IRDs) and therapies to treat patients with other retinal and refractive disorders. The pipeline includes seven adeno-associated virus (AAV)-based programs, led by OPGx-LCA5 for LCA5-related mutations and OPGx-BEST1 for BEST1-related retinal degeneration, with additional candidates targeting RHO, CNGB1, RDH12, NMNAT1, and MERTK. The company operates in one operating segment, which is the business of developing products related to vision performance and health.

Opus Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$3.73
$4.08
+11.16%
Oct 2026
$4.82
$3.67
-24.30%
Sep 2026
$3.68
$4.86
+25.94%
Aug 2026
$3.60
$3.85
+3.91%
Jul 2026
$4.05
$3.71
-9.95%
Jun 2026
$4.44
$4.12
-5.50%
May 2026
$5.15
$4.36
-14.51%
Apr 2026
$4.66
$5.10
+12.09%
Mar 2026
$4.04
$4.55
+9.37%
Feb 2026
$2.33
$4.16
+81.26%
Jan 2026
$2.27
$2.29
+14.46%
Dec 2025
$2.08
$2.00
-4.98%

Opus Share Price FAQs